Technical Analysis for EARS - Auris Medical Holding AG

Grade Last Price % Change Price Change
grade D 2.92 -0.68% -0.02
EARS closed down 0.68 percent on Friday, September 20, 2019, on 76 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical EARS trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Bearish Engulfing Bearish -0.68%
Upper Bollinger Band Walk Strength -0.68%
Volume Surge Other -5.19%
Calm After Storm Range Contraction -5.19%
Upper Bollinger Band Walk Strength -5.19%
Upper Bollinger Band Touch Strength -5.19%
Calm After Storm Range Contraction -2.99%
Upper Bollinger Band Walk Strength -2.99%
Outside Day Range Expansion -2.99%

Older signals for EARS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical trials for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss, as well as for Meniere diseases; and other development programs comprising AM-102 and AM-123 that are in preclinical studies. It has a collaboration and license agreement with Xigen S.A. to develop, manufacture, and commercialize pharmaceutical products, and drug delivery devices and formulations for the treatment of inner ear disorders. The company was formerly known as Auris Medical AG and changed its name to Auris Medical Holding AG in April 2014. Auris Medical Holding AG was founded in 1998 and is headquartered in Zug, Switzerland.
Biopharmaceutical Pharmaceutical Products Drug Delivery Nervous System Perception Hearing Loss Drug Delivery Devices Ear Hearing Tinnitus
Is EARS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 39.4
52 Week Low 2.42
Average Volume 103,263
200-Day Moving Average 5.415
50-Day Moving Average 2.7723
20-Day Moving Average 2.8475
10-Day Moving Average 2.971
Average True Range 0.1642
ADX 44.12
+DI 29.1178
-DI 11.9402
Chandelier Exit (Long, 3 ATRs ) 2.7074
Chandelier Exit (Short, 3 ATRs ) 3.1126
Upper Bollinger Band 3.112
Lower Bollinger Band 2.583
Percent B (%b) 0.64
BandWidth 18.5777
MACD Line 0.0671
MACD Signal Line 0.0557
MACD Histogram 0.0113
Fundamentals Value
Market Cap 129.44 Million
Num Shares 44.3 Million
EPS -0.75
Price-to-Earnings (P/E) Ratio -3.89
Price-to-Sales 0.00
Price-to-Book 6.14
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.11
Resistance 3 (R3) 3.11 3.04 3.08
Resistance 2 (R2) 3.04 2.99 3.04 3.07
Resistance 1 (R1) 2.98 2.96 3.01 2.98 3.06
Pivot Point 2.92 2.92 2.93 2.92 2.92
Support 1 (S1) 2.85 2.87 2.89 2.86 2.78
Support 2 (S2) 2.79 2.84 2.79 2.77
Support 3 (S3) 2.73 2.79 2.76
Support 4 (S4) 2.73